Organization in Special Consultative
Status with UN ECOSOC

2021 World Alliance Forumin San Francisco
Healthcare Game Changers:
Breakthrough Scientific Technologies Towards
Revolution of Human Society
Organized by: Alliance Forum Foundation
Virtual Meeting | November 1, 4, 8, 11, 15 & 18, 2021 (Pacific Time)2021 World Alliance Forum in San Francisco:“Healthcare Game Changers:
Breakthrough Scientific Technologies Towards Revolution of Human Society”
The ultimate goal of WAFSF is to create a society where everyone leads a healthy life – both mentally andphysically – until his/her last moment. There are three important factors to achieve this goal: (1) innovations intechnology that enables a full, healthy life even after a serious illness or injury, (2) innovations in policy thatencourage scientific and technological advances and accelerate access to them, and (3) an ecosystem where
technology and policy innovations thrive sustainably.
WAFSF will provide an information exchange, business and networking opportunities for multiple stakeholders todetermine the latest ideas, strategies and technologies to invest in for the marketing of solutions promoting ahealthy society where every person can live a healthy life until his/her last moment.

About WAFSF
Since 2013, the World Alliance Forum in San
Francisco (WAFSF) has focusedon thecommercialization and industrialization of newtechnologies
inhealthcare
fieldsincludingregenerative medicine, gene therapy, cancer
immunotherapy, and digital health.
In the past seven years, a total of nearly two
thousands leaders from the US, Japan, and othercountries, representing diverse companies fromdifferent industries, academic and research
institutions, governments, and nonprofit organizations
were in attendance. As a result of this premier,annual international conference, multiple partnerships
and countless connections were formed.
Immersion in the active discussions by leading
visionaries and unique attendee composition at
WAFSF encourages cross-industry, cross-sector, andcross-boarder collaborations, which makes WAFSF
an important destination for business development.

Dates

Pacific Time
November 1/ 4 / 8 / 11 / 15 / 18, 2021
4PM ~ 6:30PM
Japan Tokyo Time*
November 2 / 5, 2021 8AM ~ 10:30AM
November 9 / 12 / 16 / 19, 2021
9AM ~ 11:30AM

Venue Virtual meeting*Please note that the start time in Japan is shifted for one hour
after Nov. 5th due to day light saving in the US time zones.

This conference brings the best minds
together from the both sides of the Pacificalong with leaders of other parts of theworld… This conference is an accelerator – itbrings the great minds together. It sharesideas. It drives progress. It drives therapies
and outcomes, and eventually, cures.
– Robert Klein, CIRM

The most important part of the conference isthe amount of partners that are available here
for us to meet with, global partners. It hasreally opened doors for us to think about
partnering with organizations from Japanespecially here at the World Alliance Forum.
It’s been an enormous help for us as acompany. – Robin Smith, ORIG3N

I am so pleased to see that the organizers
have been able to move with the times andorganize discussions around timely, newapproaches such as gene and CAR-T celltherapy… Great hockey player Gretzky said
“You don’t aim for the puck – you aim where
you think the puck is moving toward.” That’s
what this meeting does. – Arlene Chiu, City ofHope

Forum Feature
Distinguished Speakers

High Quality Networking

Every year, WAFSF is proud tohost the world’s leading figuresand visionaries in the field. On
the picture are Nobel laureates
Dr. Shinya Yamanaka (left)and Dr. Paul Berg (right) at
2013 WAFSF.

Attendees represent different
industries, research institutions,and governmental agencies. This
unique composition of attendees
make way for new ideas andhave
resultedinmultiple
collaboration and partnershipdeals.

Business Opportunities

Compelling Agenda

Many business opportunities
are offered at WAFSF, ranging
fromsponsorships,presentations, pitch event,which give direct access to key
decision makers from theindustry,
academia,andgovernments.

From trending innovations andstartups
andfunding
andcommercialization strategies tonew regulatory frameworks, aswell as the trends on emerging
market, discussions at WAFSF
areactive,exciting,comprehensive,
andinterdisciplinary.

Speakers (Selected, 2013-2020)

ShinyaYamanaka(Kyoto U.)

PaulBerg(Stanford U.)

MasayoTakahashi(RIKEN)

DanielKraft(Singularity U.)

Akihiko
Kondo(Kobe U.)

HirotoIzumi(CabinetSecretariat)

Susan
Solomon(NYSCF)

MichaelDoherty(Roche)

RichardRoberts(New EnglandBiolabs)

Yoshiyuki
Sankai(Cyberdyne)Judy
Chou(Bayer)

Seiji
Nishino(Stanford U.)

Dale
Bredesen(Buck Institute)

TomokiTodo(Tokyo U.)

Mark
Ratain(Chicago U.)

Hideyuki
Okano(Keio U.)

GeorgeHara(DEFTA)FrancisChan(CUHK)

Tatsuya
Kondo(PMDA)

Regis
Kelly(QB3)

ToshioNakagawa
(JMA)

Brock
Reeve
(Harvard U.)

Seigo
Izumo
(Takeda)Amy
DuRoss(GE Ventures)Attendee Background50%+ Business, 20% Academic, 10% Government
Just over half of the participants represent businesses. Of the business participants,
about 50% are from large or public corporations, and the other half from startups,
small and medium companies.

90% Decision Makers
Gov’t

Out of the business participants, about 40% are key decision makers –chairpersons, presidents, board directors, CEOs or other C-level officers.
Another 50% hold middle management positions.

3,000+ Since 2013
Since 2013, more than 3,000 people have attended WAFSF. Participants come fromthe United States, Japan, China, Korea, Canada, Israel, Sweden, and several othercountries.

Governmental Agencies, Industry Groups, Media
Regulatory, policy-making, and funding officials are in attendance as well as many industry
and nonprofit groups such as ARM, FIRM, and JMA. WAFSF is covered by media outlets,
including Cell Stem Cell, BioCentury, NHK, Forbes Japan .

Past Participant Companies (Selected, 2013-2020)
AbbottFujitsu

Merrill Lynch

ROHTO Pharmaceutical

AMTD GroupGE Ventures

MIRAI TrustSanBio

Asahi Kasei Corporation

Genentech

Mitsubishi Corporation

Sangamo BioSciences

Astellas Pharma

Gladstone Institutes

Mitsubishi-Tanabe Pharma

SantenASUAHarvard Stem Cell InstituteMitsui & Co.

Shiseido

Bio-Rad Laboratories

Hitachi

Mitsui Fudosan

Silicon Valley Bank

Canon USA

Hitachi Chemical

Mizuho Securities

Singularity UniversityCapricor Therapeutics

IBM Watson HealthNEC

SMBC

Celgene Cellular Therapeutics

iFREE GroupNikon Corporation

Stanford University

Cellular Dynamics International JCR Pharmaceutical

Nippon Life Insurance

Sumitomo Dainippon Phama

ChevronJohnson & Johnson

Nitto Denko Corporation

Sutter Health

Chugai Pharmaceutical

Kaneka Americas Holding

NTT DATA

SysmexCiRA, Kyoto University

Kawasaki Heavy Industries

Olympus Corporation

Takeda Pharmaceutical

CIRM

Konica Minolta

Ono Pharmaceutical

Teijin Pharma Ltd.

Daiichi Sankyo

Kowa Company

Otsuka Pharmaceutical

The University of Tokyo

DeNAKPMG

Philips Healthcare

Thermo Fisher Scientific

DNP

Kyowa Kirin

RegeneronToshiba America Inc.

Eisai

Longevity FundRICOH

UBS Financial Services

FDALonza

RIKEN

UCSF

Fujifilm CorporationMarubeni

Roche Venture FundWalgreens

Information
Please visit WAFSF website to see the latest news, updated
agenda, supporters, and speaker biographies:
www.wafsf.org

For questions or business opportunity inquiries, pleaseemail:wafsf@allianceforum.org